A Single-Subunit NADH-Quinone Oxidoreductase Renders Resistance to Mammalian Nerve Cells against Complex I Inhibition
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 6 (3), 336-341
- https://doi.org/10.1006/mthe.2002.0674
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Recombinant Adeno-associated Virus Serotypes 2– and 5–Mediated Gene Transfer in the Mammalian Brain: Quantitative Analysis of Heparin Co-infusionMolecular Therapy, 2002
- Induction of Cell Cycle Arrest and Morphological Differentiation by Nurr1 and Retinoids in Dopamine MN9D CellsJournal of Biological Chemistry, 2001
- Lack of Complex I Activity in Human Cells Carrying a Mutation in MtDNA-encoded ND4 Subunit Is Corrected by theSaccharomyces cerevisiae NADH-Quinone Oxidoreductase (NDI1) GeneJournal of Biological Chemistry, 2001
- Overexpression of Calbindin-D28K Induces Neurite Outgrowth in Dopaminergic Neuronal Cells via Activation of p38 MAPKBiochemical and Biophysical Research Communications, 2001
- Combined Injection of rAAV with Mannitol Enhances Gene Expression in the Rat BrainMolecular Therapy, 2001
- Use of the NADH-Quinone Oxidoreductase (NDI1) Gene ofSaccharomyces cerevisiae as a Possible Cure for Complex I Defects in Human CellsJournal of Biological Chemistry, 2000
- Structure–activity relationships of some complex I inhibitorsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Mitochondrial oxidative phosphorylation defects in Parkinson's diseaseAnnals of Neurology, 1992
- Mechanism of the neurotoxicity of MPTPFEBS Letters, 1990
- Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP)+, the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Toxicology, 1988